Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells
出版年份 2019 全文链接
标题
Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells
作者
关键词
-
出版物
Cell Death & Disease
Volume 10, Issue 2, Pages -
出版商
Springer Nature
发表日期
2019-01-28
DOI
10.1038/s41419-019-1322-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Biomarker identification for statin sensitivity of cancer cell lines
- (2018) Vineet K. Raghu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins
- (2018) Federica Iannelli et al. Recent Patents on Anti-Cancer Drug Discovery
- Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells
- (2016) Andy Göbel et al. CANCER LETTERS
- The Role of Cholesterol in Cancer
- (2016) Omer F. Kuzu et al. CANCER RESEARCH
- High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer
- (2016) Siker Kimbung et al. Oncotarget
- Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
- (2016) Valentina Cappello et al. Scientific Reports
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mevalonate metabolism in cancer
- (2015) Georg Gruenbacher et al. CANCER LETTERS
- Statins are potential anticancerous agents (Review)
- (2015) ABDULLAH K. ALTWAIRGI ONCOLOGY REPORTS
- Rapid proteasomal elimination of 3-hydroxy-3-methylglutaryl-CoA reductase by interferon-γ in primary macrophages requires endogenous 25-hydroxycholesterol synthesis
- (2015) Hongjin Lu et al. STEROIDS
- Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death
- (2015) Aleksandra A. Pandyra et al. Oncotarget
- In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells
- (2014) P Jiang et al. BRITISH JOURNAL OF CANCER
- Immediate Utility of Two Approved Agents to Target Both the Metabolic Mevalonate Pathway and Its Restorative Feedback Loop
- (2014) Aleksandra Pandyra et al. CANCER RESEARCH
- Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells
- (2014) Cinzia Casella et al. GYNECOLOGIC ONCOLOGY
- Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment
- (2014) Bernard Leroy et al. HUMAN MUTATION
- Statins and breast cancer prognosis: evidence and opportunities
- (2014) Thomas P Ahern et al. LANCET ONCOLOGY
- Cholesterol and breast cancer pathophysiology
- (2014) Erik R. Nelson et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Epigenetic regulation of cholesterol homeostasis
- (2014) Steve Meaney Frontiers in Genetics
- Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial
- (2013) Olöf Bjarnadottir et al. BREAST CANCER RESEARCH AND TREATMENT
- Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells
- (2013) Carolyn A. Goard et al. BREAST CANCER RESEARCH AND TREATMENT
- Controlling Cholesterol Synthesis beyond 3-Hydroxy-3-methylglutaryl-CoA Reductase (HMGCR)
- (2013) Laura J. Sharpe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Statins and cancer: Current and future prospects
- (2012) Maja Osmak CANCER LETTERS
- Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
- (2012) William A. Freed-Pastor et al. CELL
- Targeting tumor cell metabolism with statins
- (2012) J W Clendening et al. ONCOGENE
- Mevalonate Metabolism Regulates Basal Breast Cancer Stem Cells and Is a Potential Therapeutic Target
- (2012) Christophe Ginestier et al. STEM CELLS
- Measurement of protein farnesylation and geranylgeranylation in vitro, in cultured cells and in biopsies, and the effects of prenyl transferase inhibitors
- (2011) Norbert Berndt et al. Nature Protocols
- Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma
- (2010) J. W. Clendening et al. BLOOD
- Anticancer Efficacy of Simvastatin on Prostate Cancer Cells and Tumor Xenografts Is Associated with Inhibition of Akt and Reduced Prostate-Specific Antigen Expression
- (2010) S. T. Kochuparambil et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Dysregulation of the mevalonate pathway promotes transformation
- (2010) J. W. Clendening et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer
- (2009) Elisabeth R. Garwood et al. BREAST CANCER RESEARCH AND TREATMENT
- Mutant p53 mediates survival of breast cancer cells
- (2009) L Y Lim et al. BRITISH JOURNAL OF CANCER
- Dislocation of HMG-CoA Reductase and Insig-1, Two Polytopic Endoplasmic Reticulum Proteins, En Route to Proteasomal Degradation
- (2009) Gil S. Leichner et al. MOLECULAR BIOLOGY OF THE CELL
- The Role of HMGCR Alternative Splicing in Statin Efficacy
- (2009) Marisa Wong Medina et al. TRENDS IN CARDIOVASCULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search